Letermovir 240 mg, 480 mg, 100 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Tablet / Injection

Available Strengths: 240 mg, 480 mg, 100 mg/mL

Reference Brands: Prevymis (USA/EU)

Category: Anti Viral

Letermovir is a Anti Viral product available as Tablet / Injection in strengths 240 mg, 480 mg, 100 mg/mL. It corresponds to the reference brand Prevymis (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Letermovir, marketed under the brand name Prevymis, is an antiviral medication used for the prevention and treatment of cytomegalovirus (CMV) infections. It is primarily indicated in adult patients undergoing allogeneic stem cell transplantation, where CMV infection can pose a significant risk. Letermovir works by selectively inhibiting the CMV DNA terminase complex, a key enzyme essential for viral replication, thereby preventing the virus from multiplying and spreading.

Beyond stem cell transplant patients, lettermovir shows potential benefits for other immunocompromised populations, including individuals with organ transplants or HIV infections, where CMV can lead to serious complications. The drug was initially developed by Bayer’s anti-infective division, later continued by AiCuris Anti-infective Cures AG through early clinical development, and subsequently acquired by Merck & Co. for Phase 3 trials and regulatory approval.

Available in both oral tablets and intravenous formulations, lettermovir provides flexible administration options tailored to patient needs. Its targeted mechanism and favorable safety profile make it a valuable therapy in the management of CMV infections, contributing to improved outcomes in patients with compromised immune systems and reducing the risk of CMV-related morbidity and mortality.